Details about the neuroanatomical projections from CA1 to BMAa
To view more data and metadata associated with each report, click on its ID.
Report ID | Sending structure |
Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
88648 |
Field CA1 | Basomedial nucleus of the amygdala anterior part |
light | biotinylated dextran amine (BDA) | Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Fig 4A-B, Swanson Atlas Levels 26-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y.
, 2006 |
88686 |
Field CA1 | Basomedial nucleus of the amygdala anterior part |
moderate | biotinylated dextran amine (BDA) | Collator note: BMAa is at least moderately labeled rostrocaudally. See fig. 7A-B, Swanson Atlas Levels 25-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y.
, 2006 |
---|
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Further details associated to record number 88686:
Position of injection: ventro-caudal |
Topological position of injection: is contained |
Extension of injection outside: none |
The injection was performed in: left hemisphere |
| Position of terminal field: everywhere |
Topological position of terminal field: is contained |
Extension of terminal field outside: none |
The terminal field was found: ipsilateral |
| |